Finally, we propose that a specific neuronal HERG modifier, especially for HERG3 or HERG2 channels, might be a more effective and safer pharmacological intervention than others [64] in primary prevention of SCH at high-risk individuals. This evidence concerns the gene KCNH2 and spindle cell hemangioma.